STOCKHOLM, Nov. 7, 2024 — RaySearch Laboratories AB (publ) has announced that Institut Curie, with three radiotherapy centers in Paris, Orsay, and Saint-Cloud, France, has ordered the treatment planning system RayStation®*. Institut Curie is part of the French hospital network Unicancer, and the order was placed under the Unicancer 2019 Framework agreement.

RayStation will primarily support the Institut Curie Proton Therapy Center in Orsay, one of three proton centers in France, all now equipped with RayStation.

The purchase will provide Institut Curie with access to advanced RayStation technology, such as LET optimization, adaptive planning, and AI autocontouring capabilities, for both proton and photon treatment planning.

Régis Ferrand, Head of Physics at Institut Curie, states, “Advanced key tools available in the RaySearch environment will help us bring our proton treatments to the highest quality.”

Johan Löf, founder and CEO of RaySearch, comments, “We are proud of our collaboration with Institut Curie, a well-respected hospital with an impressive legacy. The agreement is a first step; I look forward to deepening our relationship and to a fruitful collaboration.”

The total order value is approximately 1.7 MEUR excluding service agreement, with the majority recognized as revenue in the third quarter of 2024.

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00

Learn more about us on:

This information was brought to you by Cision

The following files are available for download:

 

SOURCE RaySearch Laboratories